MCA Financial Group provided critical restructuring and financial advisory services to a start-up biotech company specializing in the development of certain diagnostic devices. With 25 employees and operations based in the Southwest, the company faced insolvency due to limited remaining capital from its initial investments and a lack of revenue despite its groundbreaking work in human and animal healthcare.
MCA worked closely with the company’s CEO and Board of Directors to address these challenges and chart a path toward commercialization of its products. The engagement focused on developing and implementing a 13-week cash flow model to manage immediate operational funding needs, preparing investor presentations, and crafting a strategic plan to secure additional capital. MCA also negotiated short-term operational relief with landlords to extend the company’s runway during this critical period.
MCA’s objective and diplomatic approach helped align the Board’s focus, ensuring decisions were made with the company’s long-term interests in mind. MCA leveraged its expertise to create investor outreach materials, including a detailed pitch deck designed to attract additional investment.
This engagement highlights MCA’s expertise in delivering critical financial insights, operational planning, and strategic guidance, even in the challenging context of an early-stage, pre-revenue start-up. As a trusted advisor, MCA Financial Group consistently helps companies navigate complex restructuring scenarios, paving the way for sustainability and long-term growth.